Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease.

Together with point mutations, homozygous deletions or duplications in PARK2 are responsible for the majority of autosomal recessive juvenile Parkinsonism. It is debated, however, whether heterozygous carriers of these mutations are at increased risk of Parkinson's disease (PD). Our goal was to determine whether heterozygous carriers of copy number variants (CNVs) affecting exons of the PARK2 gene are at risk of PD that is greater than that of non-carriers. We searched for CNVs affecting exons of PARK2 in a sample of 105 749 genotyped Icelanders. In total, 989 carriers, including 24 diagnosed with PD, were identified. The heterozygous carriers were tested for association in a sample of 1415 PD patients and 40 474 controls ≥65 years of age. PD patients were more often heterozygous carriers of PARK2 CNVs than controls [odds ratio (OR) = 1.69, P = 0.03] and compound heterozygous PD patients for a CNV and a missense mutation were not found. Furthermore, we conducted a meta-analysis of studies reporting on case-control samples screened for heterozygous PARK2 CNVs. Ten studies were included in the final analysis, with 4538 cases and 4213 controls. The pooled OR and P-value for the published and Icelandic results showed significant association between PARK2 CNVs and risk of PD (OR = 2.11, P = 2.54 × 10(-6)). Our analysis shows that heterozygous carriers of CNVs affecting exons of PARK2 have greater risk of PD than non-carriers.

[1]  A. Ziegler,et al.  Next-generation phenotyping using the parkin example: time to catch up with genetics. , 2013, JAMA neurology.

[2]  W. Scott,et al.  High‐Resolution Survey in Familial Parkinson Disease Genes Reveals Multiple Independent Copy Number Variation Events in PARK2 , 2013, Human mutation.

[3]  M. Seong,et al.  Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early‐onset Parkinson disease , 2012, Clinical genetics.

[4]  J. Camacho,et al.  High frequency of Parkin exon rearrangements in Mexican‐mestizo patients with early‐onset Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[5]  M. Bramerio,et al.  Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2) , 2012, Acta Neuropathologica.

[6]  H. Stefánsson,et al.  Identification of low-frequency variants associated with gout and serum uric acid levels , 2011, Nature Genetics.

[7]  Jemma B. Wilk,et al.  Copy Number Variation in Familial Parkinson Disease , 2011, PloS one.

[8]  J. Hardy,et al.  Milestones in PD genetics , 2011, Movement disorders : official journal of the Movement Disorder Society.

[9]  Dan M Roden,et al.  A rare variant in MYH6 is associated with high risk of sick sinus syndrome , 2011, Nature Genetics.

[10]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[11]  A. Gylfason,et al.  Fine-scale recombination rate differences between sexes, populations and individuals , 2010, Nature.

[12]  G. Schellenberg,et al.  A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2 , 2010, Neurology.

[13]  Nobutaka Hattori,et al.  Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. , 2010, American journal of human genetics.

[14]  K. Marder,et al.  Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. , 2010, Archives of neurology.

[15]  Marc Cruts,et al.  Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.

[16]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[17]  Daniel F. Gudbjartsson,et al.  Parental origin of sequence variants associated with complex diseases , 2009, Nature.

[18]  K. Marder,et al.  Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations , 2009, Neurology.

[19]  C. van Broeckhoven,et al.  Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population , 2009, Human mutation.

[20]  N. Brüggemann,et al.  Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers. , 2009, Parkinsonism & related disorders.

[21]  T. Gasser.  Mendelian forms of Parkinson's disease. , 2009, Biochimica et biophysica acta.

[22]  Sonja W. Scholz,et al.  Parkin and PINK1 mutations in early-onset Parkinson’s disease: comprehensive screening in publicly available cases and control , 2009, Journal of Medical Genetics.

[23]  S. Bardien,et al.  Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. , 2009, Parkinsonism & related disorders.

[24]  Pall I. Olason,et al.  Detection of sharing by descent, long-range phasing and haplotype imputation , 2008, Nature Genetics.

[25]  C. Mariani,et al.  Parkin analysis in early onset Parkinson's disease. , 2008, Parkinsonism & related disorders.

[26]  Karen Marder,et al.  Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. , 2008, Archives of neurology.

[27]  Sonja W. Scholz,et al.  Genomewide SNP assay reveals mutations underlying Parkinson disease , 2008, Human mutation.

[28]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[29]  A. Dürr,et al.  Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls , 2007, Journal of Medical Genetics.

[30]  A. Lang,et al.  Deciphering the role of heterozygous mutations in genes associated with parkinsonism , 2007, The Lancet Neurology.

[31]  R. Marconi,et al.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease , 2007, Neurology.

[32]  K. Reetz,et al.  Phenotypic spectrum of PINK1‐associated parkinsonism in 15 mutation carriers from 1 family , 2007, Movement disorders : official journal of the Movement Disorder Society.

[33]  G. Schellenberg,et al.  Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients , 2007, Annals of neurology.

[34]  A. Verma.  Influence of Heterozygosity for Parkin Mutation on Onset Age in Familial Parkinson Disease: The GenePD Study , 2007 .

[35]  E. Sidransky,et al.  Heterozygosity for a Mendelian disorder as a risk factor for complex disease , 2006, Clinical genetics.

[36]  K. Marder,et al.  Case-control study of the parkin gene in early-onset Parkinson disease. , 2006, Archives of neurology.

[37]  P. Bauer,et al.  PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism , 2005, European Journal of Human Genetics.

[38]  D. Brooks,et al.  Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation , 2005, Neurology.

[39]  K. Marder,et al.  Distribution, type, and origin of Parkin mutations: Review and case studies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[40]  T. Dawson,et al.  Parkin-associated Parkinson’s disease , 2004, Cell and Tissue Research.

[41]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[42]  J. Noth,et al.  DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease , 2004, Neurology.

[43]  P. Lockhart,et al.  RING finger 1 mutations in Parkin produce altered localization of the protein. , 2003, Human molecular genetics.

[44]  M. Farrer,et al.  Parkin variants in North American Parkinson's disease: Cases and controls , 2003, Movement disorders : official journal of the Movement Disorder Society.

[45]  N. Quinn,et al.  The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.

[46]  Y. Agid,et al.  Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease. , 2003, Archives of neurology.

[47]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[48]  J. Haines,et al.  Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease , 2003, Annals of neurology.

[49]  L. Seeberger,et al.  Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease , 2003, Neurology.

[50]  P. McKeigue,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Problems of Reporting Genetic Associations with Complex Outcomes , 2022 .

[51]  Hreinn Stefánsson,et al.  A susceptibility gene for late‐onset idiopathic Parkinson's disease , 2002, Annals of neurology.

[52]  Nicola Pavese,et al.  Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. , 2002, Brain : a journal of neurology.

[53]  Jean-François Deleuze,et al.  Complex relationship between Parkin mutations and Parkinson disease. , 2002, American journal of medical genetics.

[54]  K. Marder,et al.  Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations , 2002, Neurology.

[55]  X. Breakefield,et al.  Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene , 2002, Movement disorders : official journal of the Movement Disorder Society.

[56]  D. Hernandez,et al.  Lewy bodies and parkinsonism in families with parkin mutations , 2001, Annals of neurology.

[57]  A. Lang,et al.  The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. , 2001, Human molecular genetics.

[58]  M. Farrer,et al.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. , 2001, American journal of human genetics.

[59]  W D Heiss,et al.  Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene , 2001, Annals of neurology.

[60]  A A Hicks,et al.  Familial aggregation of Parkinson's disease in Iceland. , 2000, The New England journal of medicine.

[61]  Kári Stefánsson,et al.  Protection of privacy by third-party encryption in genetic research in Iceland , 2000, European Journal of Human Genetics.

[62]  X. Breakefield,et al.  Parkin deletions in a family with adult‐onset, tremor‐dominant parkinsonism: Expanding the phenotype , 2000, Annals of neurology.

[63]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[64]  HOMAS,et al.  ASSOCIATION BETWEEN EARLY-ONSET PARKINSON ’ S DISEASE AND MUTATIONS IN THE PARKIN GENE , 2000 .

[65]  S. Minoshima,et al.  Polymorphism in the parkin gene in sporadic Parkinson's disease , 1999, Annals of neurology.

[66]  Y. Agid,et al.  A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. , 1999, Human molecular genetics.

[67]  N. Shimizu,et al.  Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals , 1998, Annals of neurology.

[68]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[69]  A A Schäffer,et al.  Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. , 1997, American journal of human genetics.

[70]  Rappold,et al.  Human Molecular Genetics , 1996, Nature Medicine.

[71]  S. Katz,et al.  Designing the national resident assessment instrument for nursing homes. , 1990, The Gerontologist.

[72]  Kjartan R. Gudmundsson.  A CLINICAL SURVEY OF PARKINSONISM IN ICELAND , 1967, Acta neurologica Scandinavica.

[73]  W. Penfield.  EPILEPSY, THE GREAT TEACHER , 1967 .